Press releases

  • All
  • News
  • Regulatory
  • MAR
All
  • All
  • News
  • Regulatory
  • MAR

New issue of Ingeneious, no 5 2023

Read More

Interim report January – September 2023 for CombiGene AB (publ)

Read More

CombiGene chooses Charles River as preclinical toxicology partner for COZY01 pain project

Read More

CombiGene and Zyneyro choose initial indication in the COZY01 pain project

Read More

CombiGene AB (publ): Nominating committee

Read More

Spark Therapeutics terminates collaboration agreement for the epilepsy project CG01 with CombiGene

Read More

CombiGene chooses CDMO partner for the COZY01 pain project

Read More

New issue of Ingeneious, no 4 2023

Read More
Search